EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Advances in regenerative cardiology: Stem cells versus bioartificial tissues

Jenyfer María Fuentes-Mendoza iD, Juan Muñoz-Moreno iD, Marcio Concepción-Zavaleta iD, Luis Concepción-Urteaga iD, José Paz-Ibarra iD, Roger Gonzales-Valdivieso iD, Fernanda Ginebra Castillo-Velásquez iD, Angie Sofía Burgos-Castillo iD, Regina Garza-Boullosa iD, Vanesa Daniela Núñez-Pérez iD

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.70101 ↗

At a glance

Übersichtsarbeit in European Journal of Clinical Investigation, 2025. Written by Jenyfer María Fuentes-Mendoza and 9 co-authors. Institution: School of Medicine, Universidad Científica del Sur, Lima, Peru. Major MEDLINE topics: Tissue Engineering, Regenerative Medicine, Bioartificial Organs, Stem Cell Transplantation. Cited 3 times so far (Crossref); 93 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. The human myocardium has a limited regenerative capacity, prompting the development of innovative strategies to restore cardiac function. Stem cells (SCs) and bioartificial tissues (BATs) have emerged as promising tools in regenerative cardiology for myocardial repair and functional recovery.

Methods

This review analyzes current preclinical and clinical research focused on SC‐ and BAT‐based therapies for CR. Literature was identified through comprehensive database searches. Studies evaluating cardiomyocyte differentiation, integration into host tissue, vascularisation and electromechanical properties were selected. Emphasis was placed on therapeutic potential, safety and translational challenges.

Results

SCs, including embryonic and mesenchymal stem cells, demonstrated potential to differentiate into cardiomyocyte‐like cells and contribute to myocardial restoration. When combined with biomaterial scaffolds or decellularized matrices, SCs showed improved survival, structural support, and functional integration. BATs, such as engineered heart tissue, replicated native myocardial architecture and supported synchronized contraction. Despite these advances, concerns persist regarding immunogenicity, arrhythmias, and long‐term efficacy. Technical hurdles in large‐scale production and personalised application remain unresolved.

Conclusions

SC‐ and BAT‐based therapies offer innovative avenues for repairing damaged myocardium. Their application could revolutionise treatment strategies for heart failure and post‐infarction remodelling. However, clinical translation requires addressing immune compatibility, arrhythmic risk and manufacturing limitations. Interdisciplinary collaboration and regulatory standardisation are essential for their future clinical adoption.

Subjects

MeSH terms (MEDLINE)

Tissue EngineeringRegenerative MedicineBioartificial OrgansStem Cell TransplantationCardiovascular DiseasesHumansMyocytes, CardiacCell DifferentiationTissue ScaffoldsAnimalsRegenerationMyocardial Infarction

Author keywords

bioartificial tissuesbiocompatible materialsregenerative cardiologystem cellstissue engineering

Authors and institutions

  • School of Medicine, Universidad Científica del Sur, Lima, Peru.
  • Department of Internal Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA.
  • School of Medicine, Universidad Nacional de Trujillo, Trujillo, Peru.
  • School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Department of Endocrinology, Edgardo Rebagliati Martins National Hospital, Lima, Peru.
  • School of Medicine, Universidad La Salle, Ciudad de Mexico, Mexico.

ORCID profiles: Jenyfer María Fuentes-Mendoza, Juan Muñoz-Moreno, Marcio Concepción-Zavaleta, Luis Concepción-Urteaga, José Paz-Ibarra, Roger Gonzales-Valdivieso, Fernanda Ginebra Castillo-Velásquez, Angie Sofía Burgos-Castillo, Regina Garza-Boullosa, Vanesa Daniela Núñez-Pérez

Cite

APA

Fuentes-Mendoza, J. M., Muñoz-Moreno, J., Concepción-Zavaleta, M., Concepción-Urteaga, L., Paz-Ibarra, J., Gonzales-Valdivieso, R., Castillo-Velásquez, F. G., Burgos-Castillo, A. S., Garza-Boullosa, R., & Núñez-Pérez, V. D. (2025). Advances in regenerative cardiology: Stem cells versus bioartificial tissues. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70101

Vancouver

Fuentes-Mendoza JM, Muñoz-Moreno J, Concepción-Zavaleta M, Concepción-Urteaga L, Paz-Ibarra J, Gonzales-Valdivieso R, et al. Advances in regenerative cardiology: Stem cells versus bioartificial tissues. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70101

BibTeX
@article{FuentesMendoza2025,
  author = {Fuentes-Mendoza, Jenyfer María and Muñoz-Moreno, Juan and Concepción-Zavaleta, Marcio and Concepción-Urteaga, Luis and Paz-Ibarra, José and Gonzales-Valdivieso, Roger and Castillo-Velásquez, Fernanda Ginebra and Burgos-Castillo, Angie Sofía and Garza-Boullosa, Regina and Núñez-Pérez, Vanesa Daniela},
  title = {Advances in regenerative cardiology: Stem cells versus bioartificial tissues},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.70101}
}
Start for free →